75 A new review, led by Professors Rongrong Zhou and Jie Yang from Xiangya Hospital at Central South University, has provided a detailed analysis of recent advancements in the understanding and treatment of metastatic brain tumours. These tumours, particularly those originating from lung, breast, and melanoma cancers, present a major challenge in oncology, often accompanied by poor prognosis and limited survival times. The study, published in the Journal MedComm, highlights significant progress in both preclinical research and clinical therapies, offering a hopeful outlook for future treatment strategies. This comprehensive review is the first to examine the evolving landscape of metastatic brain tumours, with a focus on advancements in preclinical model systems, a deeper understanding of underlying biological mechanisms, and the integration of cutting-edge technologies such as multi-omics and artificial intelligence. The review underscores the growing complexity of the disease, which is influenced by the blood-brain barrier, the brain’s unique microenvironment, and subtle changes that occur during metastasis. These factors make brain metastasis distinctly different from primary tumours. The team’s research emphasises the importance of multi-omics approaches, which combine genomic, proteomic, and transcriptomic data to gain new insights into tumour biology. These advancements are helping researchers identify new molecular targets for treatment. Artificial intelligence, imaging genomics, and transcriptomics are also playing an increasingly important role in improving diagnostic techniques and enhancing the precision of treatment options. These technologies allow for a more comprehensive understanding of tumour characteristics, enabling clinicians to offer more tailored and effective treatments. Guilong Tanzhu, the study’s lead author, explained that the integration of multi-omics and artificial intelligence is transforming the field of metastatic brain tumour research. “In the era of multi-omics and artificial intelligence, a comprehensive understanding of metastatic brain tumours, both clinically and preclinically, has significantly advanced diagnosis and treatment,” he said. This multidisciplinary approach is making it possible to tackle the complexities of brain metastasis more effectively, offering hope for patients who currently have limited treatment options. Metastatic brain tumours are particularly prevalent in patients with advanced lung cancer, breast cancer, and melanoma. These tumours are notoriously difficult to treat, and patients often face a survival period that rarely extends beyond a few months. Despite these challenges, the review suggests that research is making headway in improving prognosis. As survival rates for primary cancers continue to improve due to earlier diagnosis and better treatments, the incidence of brain metastasis is on the rise, highlighting the pressing need for enhanced treatment strategies specifically aimed at brain metastasis. The study also discusses the challenges associated with translating preclinical advances into clinical success. One of the primary obstacles in treating metastatic brain tumours is overcoming the complexities of the tumour microenvironment and the blood-brain barrier. However, the review underscores that scientific and technological advancements are shedding new light on metastatic brain tumours, with multi-omics research and artificial intelligence offering promising new avenues for treatment. As diagnostic capabilities continue to improve and treatment for primary cancers advances, the study notes that curing metastatic brain tumours may be within reach. Researchers are hopeful that these technological breakthroughs will lead to more effective therapies in the near future. The ability to integrate detailed molecular data and create personalised treatment plans represents a significant step forward in the fight against these aggressive cancers. While challenges remain in the battle against metastatic brain tumours, the progress made so far provides a sense of optimism. The integration of innovative research techniques and advanced technologies has the potential to revolutionise the treatment of metastatic brain tumours, offering new hope to patients who are currently faced with limited options. As the understanding of these tumours continues to deepen, scientists are poised to make further strides towards improving diagnosis, treatment, and ultimately, survival rates for patients suffering from this devastating disease.